Urokinase Receptor and Resistance to Targeted Anticancer Agents
The urokinase receptor/uPAR is a GPI-anchored membrane protein, which regulates protease activity at the cell surface and, in collaboration with a system of co-receptors, triggers cell-signaling and regulates gene expression within the cell. In normal tissues, uPAR gene expression is limited; howev...
| Published in: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | Steven L. Gonias, Jingjing eHu |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2015-07-01
|
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00154/full |
Similar Items
Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs
by: Yu-Ching Chang, et al.
Published: (2023-10-01)
by: Yu-Ching Chang, et al.
Published: (2023-10-01)
Let-7 Family microRNAs Regulate the Expression of the Urokinase-Receptor in Acute Myeloid Leukemia Cells
by: Anna Li Santi, et al.
Published: (2025-04-01)
by: Anna Li Santi, et al.
Published: (2025-04-01)
Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator
by: Mostafa Hamada, et al.
Published: (2024-05-01)
by: Mostafa Hamada, et al.
Published: (2024-05-01)
Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention
by: Julie Maja Leth, et al.
Published: (2021-08-01)
by: Julie Maja Leth, et al.
Published: (2021-08-01)
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
by: Ashna A. Kumar, et al.
Published: (2022-01-01)
by: Ashna A. Kumar, et al.
Published: (2022-01-01)
<i>Helicobacter pylori</i> Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early Pathogenesis
by: Warner Alpízar-Alpízar, et al.
Published: (2020-07-01)
by: Warner Alpízar-Alpízar, et al.
Published: (2020-07-01)
Urokinase-Type Plasminogen Activator System in Norm and in Life-Threatening Processes (Review)
by: Elena V. Kugaevskaya, et al.
Published: (2018-12-01)
by: Elena V. Kugaevskaya, et al.
Published: (2018-12-01)
Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR
by: Junwei Hou, et al.
Published: (2015-08-01)
by: Junwei Hou, et al.
Published: (2015-08-01)
MIF promotes cell invasion by the LRP1-uPAR interaction in pancreatic cancer cells
by: Huizhi Sun, et al.
Published: (2023-01-01)
by: Huizhi Sun, et al.
Published: (2023-01-01)
Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion
by: Matthew G. Annis, et al.
Published: (2018-01-01)
by: Matthew G. Annis, et al.
Published: (2018-01-01)
Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
by: Felix Oh, et al.
Published: (2020-06-01)
by: Felix Oh, et al.
Published: (2020-06-01)
Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression
by: Murat Albayrak, et al.
Published: (2010-09-01)
by: Murat Albayrak, et al.
Published: (2010-09-01)
Получение специфичных к антигену CD87 CAR T-лимфоцитов и оценка их функциональной активности in vitro
by: М. В. Неклесова, et al.
Published: (2022-10-01)
by: М. В. Неклесова, et al.
Published: (2022-10-01)
Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection
by: Liqiang Zhang, et al.
Published: (2023-08-01)
by: Liqiang Zhang, et al.
Published: (2023-08-01)
Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Min Ma, et al.
Published: (2022-04-01)
by: Min Ma, et al.
Published: (2022-04-01)
ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of α1,3-mannosylated uPAR and ADAM8
by: Xinyuan Cui, et al.
Published: (2022-10-01)
by: Xinyuan Cui, et al.
Published: (2022-10-01)
Communication Between Epithelial–Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression
by: Xiaobo Zheng, et al.
Published: (2021-04-01)
by: Xiaobo Zheng, et al.
Published: (2021-04-01)
New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms
by: Anna Gorrasi, et al.
Published: (2020-11-01)
by: Anna Gorrasi, et al.
Published: (2020-11-01)
Pro-Inflammatory Protein PSCA Is Upregulated in Neurological Diseases and Targets β2-Subunit-Containing nAChRs
by: Mikhail A. Shulepko, et al.
Published: (2025-09-01)
by: Mikhail A. Shulepko, et al.
Published: (2025-09-01)
RSK3 switches cell fate: from stress-induced senescence to malignant progression
by: Anda Huna, et al.
Published: (2023-11-01)
by: Anda Huna, et al.
Published: (2023-11-01)
A gradual path to mortality
by: Na Yang, et al.
Published: (2022-03-01)
by: Na Yang, et al.
Published: (2022-03-01)
Selective targeting of α7 nicotinic acetylcholine receptor by synthetic peptide mimicking loop I of human SLURP-1 provides efficient and prolonged therapy of epidermoid carcinoma in vivo
by: O. V. Shlepova, et al.
Published: (2023-10-01)
by: O. V. Shlepova, et al.
Published: (2023-10-01)
Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
by: Kaibo Guo, et al.
Published: (2021-04-01)
by: Kaibo Guo, et al.
Published: (2021-04-01)
In Search of the Role of Three-Finger Starfish Proteins
by: Ekaterina N. Lyukmanova, et al.
Published: (2024-10-01)
by: Ekaterina N. Lyukmanova, et al.
Published: (2024-10-01)
CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
by: Daan Linders, et al.
Published: (2021-03-01)
by: Daan Linders, et al.
Published: (2021-03-01)
uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study
by: Marie Øbro Fosbøl, et al.
Published: (2021-06-01)
by: Marie Øbro Fosbøl, et al.
Published: (2021-06-01)
Human antibody VH domains targeting uPAR as candidate therapeutics for cancers
by: Xiaojie Chu, et al.
Published: (2023-10-01)
by: Xiaojie Chu, et al.
Published: (2023-10-01)
Prospective phase II trial of [68Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy
by: Aleena Azam, et al.
Published: (2024-10-01)
by: Aleena Azam, et al.
Published: (2024-10-01)
Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting
by: Mahmoud Al-Azab, et al.
Published: (2022-08-01)
by: Mahmoud Al-Azab, et al.
Published: (2022-08-01)
Mesenchymal Stem Cell Senescence and Osteogenesis
by: Artaria Tjempakasari, et al.
Published: (2021-12-01)
by: Artaria Tjempakasari, et al.
Published: (2021-12-01)
Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer
by: Joyce Y. Buikhuisen, et al.
Published: (2023-03-01)
by: Joyce Y. Buikhuisen, et al.
Published: (2023-03-01)
High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions
by: André Luiz Lourenço, et al.
Published: (2023-12-01)
by: André Luiz Lourenço, et al.
Published: (2023-12-01)
Cancer spreading patterns based on epithelial-mesenchymal plasticity
by: Rui Wang, et al.
Published: (2024-04-01)
by: Rui Wang, et al.
Published: (2024-04-01)
New Three-Finger Protein from Starfish <i>Asteria rubens</i> Shares Structure and Pharmacology with Human Brain Neuromodulator Lynx2
by: Alexander S. Paramonov, et al.
Published: (2022-08-01)
by: Alexander S. Paramonov, et al.
Published: (2022-08-01)
Editorial: Understanding the mesenchymal to epithelial transition: a much needed angle for epithelial mesenchymal plasticity
by: Hani Alotaibi, et al.
Published: (2024-10-01)
by: Hani Alotaibi, et al.
Published: (2024-10-01)
Does cellular senescence play an important role in the prognosis of sarcomatoid carcinoma of the pancreas?
by: Toshihisa Kimura, et al.
Published: (2021-03-01)
by: Toshihisa Kimura, et al.
Published: (2021-03-01)
Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms
by: Rekha Gahtori, et al.
Published: (2023-02-01)
by: Rekha Gahtori, et al.
Published: (2023-02-01)
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells
by: Fatima Junaid, et al.
Published: (2023-02-01)
by: Fatima Junaid, et al.
Published: (2023-02-01)
Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
by: Renata Marietta Bocskei, et al.
Published: (2020-02-01)
by: Renata Marietta Bocskei, et al.
Published: (2020-02-01)
Mesenchymal Stem Cell-Like Properties in Fibroblasts
by: Yuqiao Chang, et al.
Published: (2014-08-01)
by: Yuqiao Chang, et al.
Published: (2014-08-01)
Similar Items
-
Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs
by: Yu-Ching Chang, et al.
Published: (2023-10-01) -
Let-7 Family microRNAs Regulate the Expression of the Urokinase-Receptor in Acute Myeloid Leukemia Cells
by: Anna Li Santi, et al.
Published: (2025-04-01) -
Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator
by: Mostafa Hamada, et al.
Published: (2024-05-01) -
Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention
by: Julie Maja Leth, et al.
Published: (2021-08-01) -
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
by: Ashna A. Kumar, et al.
Published: (2022-01-01)
